Cargando…

Asymmetric Dopaminergic Degeneration and Attentional Resources in Parkinson’s Disease

Background: Attention is crucial to voluntary perform actions in Parkinson’s disease (PD), allowing patients to bypass the impaired habitual motor control. The asymmetrical degeneration of the dopaminergic system could affect the attentional functions. Objective: To investigate the relationship betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortelli, Paola, Ferrazzoli, Davide, Zarucchi, Marianna, Maestri, Roberto, Frazzitta, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304447/ https://www.ncbi.nlm.nih.gov/pubmed/30618591 http://dx.doi.org/10.3389/fnins.2018.00972

Ejemplares similares

How Cognition and Motivation “Freeze” the Motor Behavior in Parkinson’s Disease
por: Ortelli, Paola, et al.
Publicado: (2019)

Focused and Sustained Attention Is Modified by a Goal-Based Rehabilitation in Parkinsonian Patients
por: Ferrazzoli, Davide, et al.
Publicado: (2017)

Italian validation of the Belastungsfragebogen Parkinson kurzversion (BELA-P-k): a disease-specific questionnaire for evaluation of the subjective perception of quality of life in parkinson’s disease
por: Ortelli, Paola, et al.
Publicado: (2017)

Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson’s Disease: Implications for Rehabilitation
por: Ferrazzoli, Davide, et al.
Publicado: (2016)

Does Cognitive Impairment Affect Rehabilitation Outcome in Parkinson’s Disease?
por: Ferrazzoli, Davide, et al.
Publicado: (2016)

Efficacy of intensive multidisciplinary rehabilitation in Parkinson’s disease: a randomised controlled study
por: Ferrazzoli, Davide, et al.
Publicado: (2018)

Occupational Therapy for Parkinsonian Patients: A Retrospective Study
por: Franciotta, Michele, et al.
Publicado: (2019)

Severe Constipation in Parkinson's Disease and in Parkinsonisms: Prevalence and Affecting Factors
por: Frazzitta, Giuseppe, et al.
Publicado: (2019)

Optimization of cognitive assessment in Parkinsonisms by applying artificial intelligence to a comprehensive screening test
por: Ortelli, Paola, et al.
Publicado: (2022)

Motivational and myopic mechanisms underlying dopamine medication-induced impulsive-compulsive behaviors in Parkinson's disease
por: Dawson, Andrew, et al.
Publicado: (2023)

Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in “de-novo” Parkinsonian subjects: a randomized controlled trial with 18-month follow-up
por: Ferrazzoli, D., et al.
Publicado: (2018)

Balance Dysfunction in Parkinson's Disease: The Role of Posturography in Developing a Rehabilitation Program
por: Ferrazzoli, Davide, et al.
Publicado: (2015)

Looking deeper: does a connection exist between fatigue and attentional deficits in Parkinson's disease? A conceptual framework
por: Ortelli, Paola, et al.
Publicado: (2023)

Multidisciplinary intensive rehabilitation treatment improves sleep quality in Parkinson’s disease
por: Frazzitta, Giuseppe, et al.
Publicado: (2015)

Global slowness and increased intra-individual variability are key features of attentional deficits and cognitive fluctuations in post COVID-19 patients
por: Ortelli, Paola, et al.
Publicado: (2022)

Pisa Syndrome in Parkinson's Disease: Electromyographic Aspects and Implications for Rehabilitation
por: Frazzitta, Giuseppe, et al.
Publicado: (2015)

Crossover versus Stabilometric Platform for the Treatment of Balance Dysfunction in Parkinson's Disease: A Randomized Study
por: Frazzitta, G., et al.
Publicado: (2015)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Stigma Experienced by Parkinson's Disease Patients: A Descriptive Review of Qualitative Studies
por: Maffoni, Marina, et al.
Publicado: (2017)

Effectiveness of aquatic versus land physiotherapy in the treatment of peripheral neuropathies: a randomized controlled trial
por: Zivi, Ilaria, et al.
Publicado: (2017)

Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
por: Grosch, Janina, et al.
Publicado: (2016)

Differences in Muscle Strength in Parkinsonian Patients Affected on the Right and Left Side
por: Frazzitta, Giuseppe, et al.
Publicado: (2015)

Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments
por: Clerici, Ilaria, et al.
Publicado: (2017)

Early Rehabilitation Reduces Time to Decannulation in Patients With Severe Acquired Brain Injury: A Retrospective Study
por: Zivi, Ilaria, et al.
Publicado: (2018)

Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism
por: Monnot, Cyril, et al.
Publicado: (2017)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
por: Hanganu, Alexandru, et al.
Publicado: (2014)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Effectiveness of a Very Early Stepping Verticalization Protocol in Severe Acquired Brain Injured Patients: A Randomized Pilot Study in ICU
por: Frazzitta, Giuseppe, et al.
Publicado: (2016)

Sexual dysfunction precedes motor defects, dopaminergic neuronal degeneration, and impaired dopamine metabolism: Insights from Drosophila model of Parkinson’s disease
por: Koza, Zevelou, et al.
Publicado: (2023)

Experimental Protocol to Test Explicit Motor Learning–Cerebellar Theta Burst Stimulation
por: Ortelli, Paola, et al.
Publicado: (2021)

Effect of Dopaminergic Medication on Postural Sway in Advanced Parkinson’s Disease
por: Revilla, Fredy J., et al.
Publicado: (2013)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
por: Brichta, Lars, et al.
Publicado: (2014)

Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
por: Dujardin, Kathy, et al.
Publicado: (2020)

The need for psychological, caregiver‐centered intervention in the time of COVID‐19
por: Ortelli, Paola, et al.
Publicado: (2021)

Dopaminergic Medication Modulates Learning from Feedback and Error-Related Negativity in Parkinson’s Disease: A Pilot Study
por: Volpato, Chiara, et al.
Publicado: (2016)

The Effect of Dopaminergic Medication on Beat-Based Auditory Timing in Parkinson’s Disease
por: Cameron, Daniel J., et al.
Publicado: (2016)

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s Disease
por: Erga, Aleksander H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_je5i0t3quc5b9mv1385mlt9k3p